✦ LIBER ✦

HLA-G Expression as a Prognostic Indicator in B-Cell Chronic Lymphocytic Leukemia

✍ Scribed by Attia, Mohamed A.; Nosair, Nahla A.; Gawally, Amro; Elnagar, Gamal; Elshafey, Eid M.

Book ID: 121706428
Publisher: S. Karger AG
Year: 2014
Tongue: English
Weight: 723 KB
Volume: 132
Category: Article
ISSN: 0001-5792
DOI: 10.1159/000353757

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prognostic irrelevance of HLA-G in B-cel

Prognostic irrelevance of HLA-G in B-cell chronic lymphocytic leukemia

✍ G. PEREZ-CHACON; S. ROSADO; N. REBOLLEDA; I. LOSADA-FERNANDEZ; J. A. VARGAS; M. 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 233 KB

CD38 expression as an important prognost

CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia

✍ Ibrahim, S. 📂 Article 📅 2001 🏛 American Society of Hematology 🌐 English ⚖ 133 KB

The significance of soluble HLA-G plasma

The significance of soluble HLA-G plasma levels as well as messenger HLA-G for B-cell chronic lymphocytic leukemia (B-CLL)

✍ K. Giannopoulos; M. Schmitt; M. Kowal; P. Własiuk; A. Bojarska-Junak; J. Rolińsk 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 149 KB

Lipoprotein lipase expression is a novel

Lipoprotein lipase expression is a novel prognostic factor in B-cell chronic lymphocytic leukemia

✍ Nückel, Holger; Hüttmann, Andreas; Klein-Hitpass, Ludger; Schroers, Roland; Führ 📂 Article 📅 2006 🏛 Informa plc 🌐 English ⚖ 580 KB

CD1d expression as a prognostic marker f

CD1d expression as a prognostic marker for chronic lymphocytic leukemia

✍ Anastasiadis, Athanasios; Kotsianidis, Ioannis; Papadopoulos, Vasileios; Spanoud 📂 Article 📅 2013 🏛 Informa plc 🌐 English ⚖ 313 KB

Expression of TCL-1 as a potential progn

Expression of TCL-1 as a potential prognostic factor for treatment outcome in B-cell chronic lymphocytic leukemia

✍ Rebekah L. Browning; Susan M. Geyer; Amy J. Johnson; Diane F. Jelinek; Renee C. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 208 KB

TCL-1 expression is variable in CLL, and no study has examined its association with treatment response. We measured TCL-1 protein in CLL cells from 51 patients who then received pentostatin, cyclophosphamide, and rituximab. TCL-1 expression did not correlate with any pre-treatment characteristics. L